CMS Open Payments · Program Year 2024
Noah Medical Corporation
Noah Medical Corporation reported $1,152,020.81 across General Payments, Research, and Ownership to 1,750 physicians and teaching hospitals across 1,750 transactions.
- $1.2M Above-median payer
- All-tracks total
- 1,750 Top quartile volume
- Transactions
- 1,750 Top quartile reach
- Recipients
- +$563.8K
- General Payments vs PY2023
Noah Medical Corporation reported $1,152,020.81 across all CMS Open Payments tracks (General + Research + Ownership) to 1,750 physicians and teaching hospitals in Program Year 2024 - ranking #589 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,152,020.81, averaging $658.30 per recipient.
Noah Medical Corporation's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
33/100
Total payments
F
21/100
Transaction volume
F
23/100
Physician reach
F
23/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer noah-medical-corporation Noah Medical Corporation
$1.2M · #589/1,925 · 0.0% industry · PY2024
- TOT $1.2M
- RANK #589
- SHARE 0.0%
- TXN 1,750
- RCP 1,750
- CAT 5
- GEN $1.2M
- ΔGEN +$563.8K
- TOP1 15.9%
- PY 2024
Volume peers
Nearest volume peer: Occlutech US LLC ($1.2M)
Noah Medical Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Noah Medical Corporation's CMS-reported General Payments increased by $563.8K (+95.9%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2023: NOAH MEDICAL CORPORATIONPY2024: Noah Medical Corporation. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $588,197.54
- PY2024
- $1,152,020.81
What the Data Shows for Noah Medical Corporation
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Noah Medical Corporation that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
245 transactions worth $641.5K make "Consulting Fee" the top general-payment category in the 5-category breakdown below, 55.7% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Noah Medical Corporation made 5 types of general payments. "Consulting Fee" is the largest category at $641.5K, 55.7% of General Payments.
Noah Medical Corporation reports 5 general-payment categories - the top three are Consulting Fee (55.7%), Compensation for Faculty or Speaker (Medical Education) (17.6%), and Travel and Lodging (11.8%). The remaining 2 categories make up 14.8% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Noah Medical Corporation divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $641.5K | 245 | 55.7% |
| Compensation for Faculty or Speaker (Medical Education) | $203.3K | 67 | 17.6% |
| Travel and Lodging | $136.3K | 425 | 11.8% |
| Food and Beverage | $92.7K | 985 | 8.0% |
| Compensation for Services Other Than Consulting | $78.3K | 28 | 6.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $798,045.84 (69.3%) of $1,152,020.81 in this company's General Payments records across 230 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Noah Medical Corporation
The five named recipients with the highest reported General Payments from this company
- 1
Amit Kumar Mahajan
$182,955.68 across 129 reported transactions
- 2
DOUGLAS Hogarth
$170,609.85 across 193 reported transactions
- 3
Krishnendu Bhadra
$156,206.64 across 92 reported transactions
- 4
Sean P Callahan
$154,486.52 across 83 reported transactions
- 5
Stephen P Kovacs
$133,787.15 across 85 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Noah Medical Corporation ranks #589 of 1,925 by total payments (top 31% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #985 of 1,838 by HHI (bottom 46% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Voom Medical Devices, Inc. : $76.9K total payments, HHI 1125
- Cryo Specialty Medical, LLC : $117.5K total payments, HHI 1121
- MeMed US, Inc. : $7.7K total payments, HHI 1121
- MiRus, LLC : $236.9K total payments, HHI 1119
- Echosens North America, Inc. : $149.4K total payments, HHI 1118
- Curium US LLC : $45.9K total payments, HHI 1118
- Noah Medical Corporation (this company) : $1.2M total payments, HHI 1114
- Life Technologies Corporation : $868.1K total payments, HHI 1114
- TearLab Corp : $77.8K total payments, HHI 1113
- American Regent : $64.2K total payments, HHI 1109
- Rigicon,Inc. : $933.53 total payments, HHI 1108
- Monteris Medical Corporation : $197.5K total payments, HHI 1107
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Noah Medical Corporation's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Noah Medical Corporation.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Noah Medical Corporation.
Showing 6 of 1,924 companies with CMS-reported payment data.
Revance Therapeutics, Inc.
New Wave Endo-Surgical Corp.
Ossio Ltd
Gynesonics, Inc.
Fisher & Paykel Healthcare Limited
Put this to use
Noah Medical Corporation ranks #589 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where Noah Medical Corporation sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Noah Medical Corporation. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.